Reviews |

Nonpharmacologic Treatment of Atrial Fibrillation : Current and Evolving Strategies FREE TO VIEW

Demosthenes Iskos; Gerard J. Fahy; Keith G. Lurie; Scott Sakaguchi; Wayne O. Adkisson; David G. Benditt
Author and Funding Information

From the Cardiac Arrhythmia Center, Department of Medicine, University of Minnesota Medical School, Minneapolis

1997 by the American College of Chest Physicians

Chest. 1997;112(4):1079-1090. doi:10.1378/chest.112.4.1079
Text Size: A A A
Published online


Atrial fibrillation is the most common cardiac arrhythmia requiring treatment. Limitations of medical treatment have prompted development of nonpharmacologic therapies for this arrhythmia. These are aimed at ventricular rate control during atrial fibrillation, termination of the arrhythmia, and/or prevention of recurrences. Ventricular rate control can be achieved with transcatheter ablation or modification of the atrioventricular node. The MAZE operation is effective in preventing arrhythmia recurrence, but because it requires cardiac surgery, its appeal is limited. Development of the technique for direct transcatheter ablation of atrial fibrillation is eagerly anticipated and may represent the standard curative treatment of the future. In appropriately selected patients, implantable device therapy may play an important role in the treatment of paroxysmal atrial fibrillation.




Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543